Roxadustat treatment improved insulin action on glycogen synthesis in myotubes from donors with type 2 diabetes, suggesting that perturbations affecting the HIF pathway may be a novel way to improve metabolism in insulin-resistant individuals. Here, INS is linked to type 2 diabetes mellitus.